A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo

Human Gene Therapy

Volumn 7, Issue 14, 1996, Pages 1735-1742

  Bowles, Neil E ^a   Eisensmith, Randy C ^a   Mohuiddin, Rehana ^a   Pyron, Milton ^a   Woo, Savio L C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA GALACTOSIDE; LIVER ENZYME;

ANIMAL CELL; ARTICLE; CELL LABELING; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; LIVER CELL; MALE; NONHUMAN; PARTIAL HEPATECTOMY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; RETROVIRUS; SUPERNATANT; TARGET ORGAN; ULTRACENTRIFUGATION; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS RECOMBINANT;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029849764     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.14-1735     Document Type: Article

References (22)

1. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.-K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian cells and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
2. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.-M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
3. GOFF, S., TRAKTMAN, P., and BALTIMORE, D. (1981). Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J Virol. 38, 239-248.
4. 3. Cancer Res. 22, 842-849.
5. KALEKO, M., GARCIA, J.V., and MILLER, A.D. (1991). Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum. Gene Ther. 2, 27-32.
6. KAY, M.A., LI, L., LIU, T.J., LELAND, F., TOMAN, C., FINEGOLD, M., and WOO, S.L.C. (1992). Hepatic gene therapy: persistent expression of human alphal-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641-647.
7. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M, and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262, 117-119.
8. KAY, M.A., and WOO, S.L.C. (1994). Gene Therapy for metabolic disorders. Trends Genet. 10, 253-257.
9. KOLODKA, T.M., FINEGOLD, M., KAY, M.A., and WOO, S.L.C. (1993). Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo. Somat. Cell Mol. Genet. 19, 491-497.
10. KOLODKA, T.M., FINEGOLD, M., MOSS, L., and WOO, S.L.C. (1995). Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc. Natl. Acad. Sci. USA 92, 3293-3297.
11. KOTANI, H., NEWTON, P.B., ZHANG, S., CHIANG, Y.L., OTTO, E., WEAVER, L., BLAESE, R.M., ANDERSON, W.F., and MCGARRITY, G.J. (1994). Improved methods of retroviral transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
12. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
13. LIU, M.-L., WINTHER, B.L., and KAY, M.A. (1996) Pseudo-transduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotrophic vectors for hepatic gene transfer. J. Virol. 70, 2497-2502.
14. MARKOWITZ, D., GOFF, S., and BANK, A. (1988) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
15. McGRATH, M., WHITE, O., PINCUS, T., and WEISSMAN, I.L. (1978). Retrovirus purification: Method that conserves envelope glycoprotein and maximizes infectivity. J. Virol. 25, 923-927.
16. PAGÈS, J.-C., LOUX, N., FARGE, D., BRIAND, P., and WEBER, A. (1995). Activation of Moloney murine leukemia virus LTR enhances the titer of recombinant retrovirus in Ψ CRIP packaging cells. Gene Ther. 2, 547-551.
17. PONDER, K.P., GUPTA, S., LELAND, F., DARLINGTON, G., FINEGOLD, M., DEMAYO, J., LEDLEY, F.D., CHOWDHURY, J.R., and WOO, S.L. (1991). Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88, 1217-1221.
18. SCHLEGEL, R., WILLINGHAM, M.C., and PASTAN, I.H. (1982). Saturatable binding sites for vesicular stomatitis virus on the surface of vero cells. J. Virol. 43, 871-875.
19. STRAUSS, M. (1994). Liver-directed gene therapy: prospects and problems. Gene Ther. 1, 156-164.
20. WITTE, O.N., WEISSMAN, I.L., and KAPLAN, H.S. (1973). Structural characteristics of some murine RNA tumor viruses studied by lactoperoxidase iodination. Proc. Natl. Acad. Sci. USA 70, 36-40.
21. YEE, J.K., MIYANOHARA, A., LAPORTE, P., BOUIC, K., BURNS, J.C., and FRIEDMAN, T. (1994) A general method for the generation of high titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91, 9564-9568.
22. ZHANG, H., DUAN, L.-X., DORNADULA, G., and POMERANTZ, R.J. (1995). Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: Potential utility for genetic therapies. J. Virol. 69, 3929-3932.